200.51—Aqueous-based drug products for oral inhalation.
(a)
All aqueous-based drug products for oral inhalation must be manufactured to be sterile.
(b)
Manufacturers must also comply with the requirements in § 211.113(b) of this chapter.
Code of Federal Regulations
[65 FR 34089, May 26, 2000]